Feb 29 |
Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Editas (EDIT) Q4 Earnings & Revenues Top Estimates, Stock Up
|
Feb 29 |
Q4 2023 Editas Medicine Inc Earnings Call
|
Feb 28 |
Editas Medicine files for mixed shelf offering
|
Feb 28 |
Editas Medicine: Several Catalysts For Reni-Cel In 2024 Make This A Must Watch
|
Feb 28 |
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Feb 28 |
Editas Medicine, Inc. (EDIT) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Editas spikes as Vertex Pharma deal boosts Q4 topline
|
Feb 28 |
Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
|
Feb 28 |
Editas Medicine Inc (EDIT) Reports Improved Financials and Advances in Gene Editing Trials
|